| Project/Area Number |
03454518
|
|---|
| Research Category |
Grant-in-Aid for General Scientific Research (B)
|
| Allocation Type | Single-year Grants |
|---|
| Research Field |
内分泌・代謝学
|
|---|
| Research Institution | The University of Tokushima |
|---|
Principal Investigator |
ITAKURA Mitsuo Sch Med, Univ Tokushima, Prof., 医学部, 客員教授 (60134227)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
IWAHANA Hiroyuki Sch Med, Univ Tokushima, Res Assist., 医学部, 客員教員助手担当
YOSHIMOTO Katsuhiko Sch Med, Univ Tokushima Assoc Prof., 医学部, 客員助教授 (90201863)
岡 達三 徳島大学, 医学部, 助教授 (50116795)
宮崎 純一 東京大学, 医学部, 客員教授 (10200156)
|
|---|
| Project Period (FY) |
1991 – 1992
|
| Project Status |
Completed (Fiscal Year 1992)
|
| Budget Amount *help |
¥6,500,000 (Direct Cost: ¥6,500,000)
Fiscal Year 1992: ¥1,900,000 (Direct Cost: ¥1,900,000)
Fiscal Year 1991: ¥4,600,000 (Direct Cost: ¥4,600,000)
|
|---|
| Keywords | gene therapy / B-cells of pancreatic islets / diabetes mellitus / fibroblasts / proinsulin / glucose-dependency / insulin gene |
|---|
| Research Abstract |
The principle of controling insulin gene expression in somatic cell gene therapy was studied in three ways. The first method used fibroblasts which secrete human proinsulin by recombinant technology. these fibroglasts were transfected with the second recombinant plasmid encoding mouse genomic CD8.2 gene. These doubly transfected cells were trans-planted intraperitoneally to streptozocin-induced diabetic C3H mice. The blood glucose concentrations were remarkably decreased from 430 mg/dl of the pre-treatment level to 80 mg/dl at the 30th day after the transplantation. To remove the transplanted cells, anti-CD8.2 monoclonal antibody was administered, which lead to the reversal of blood glucose level to the pre-treatment level, proving the complete removal of transplanted cells. The second method used MIN-6 cells which originated from transgenic mice with a Rat-Insulin-Promoter-T-antigen transgene. The transplantation of this cell line to diabetic C57BL06 mice immediately improved blood glucose levels to the normal range. Along with the time after transplantation, glucose responsiveness of transplanted cells decreased as estimated by glucose tolerance test. Thirdly glucose-dependent mechanism of insulin secretion in this B-cell line was examined by culturing this cell line in different glucose concentrations, which showed minimul change of insulin mRNA in contrast to 6-fold difference of insulin secretion. This suggests the importance of translational control rather than transcriptional control. The future study on the glucose-dependent regulation of insulin secretion should be directed to the molecular analysis of glucose-dependency in this MIN-6 cell line. It is also important to use B-cell-derived cell lines as well as fibroblasts as the possible target of somatic cell gene therapy against diabetes.
|
